Tuesday, December 6, 2022
HomeHealthHere's why Biogen's promising Alzheimer's drug data is also good news for...

Here’s why Biogen’s promising Alzheimer’s drug data is also good news for Eli Lilly

We don’t own Eli Lilly exclusively for its potential Alzheimer’s treatment. However, we still find Biogen’s topline data to be very encouraging for Lilly.

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Most Popular

%d bloggers like this: